Elekta Reinforces Strong China-Asia Presence at 2012 ChinaMed Exhibition, Demonstrates Broad Range of Radiotherapy Solutions

BEIJING, March 21, 2012 /PRNewswire/ -- At the 24th International Medical Instruments & Equipment (ChinaMed) Exhibition, March 23-25 at the China National Convention Center in Beijing, Elekta (booth #3A001) will showcase its comprehensive range of oncology solutions and demonstrate its preeminence as the dominant provider of radiation therapy technology in China.

In the last five years, Elekta has concentrated resources to support China's unprecedented initiatives to modernize and improve access to cancer management technology. This has resulted in a number of firsts and milestones for both Elekta and Chinese medical centers:

• This month, Elekta BMEI shipped its 100th Elekta Compact™ treatment system, equipped with the 2,000th Precise Table manufactured by Elekta. The 100th Elekta Compact will be will be shipped to Fujian Province Tumor Hospital.
• Release of MOSAIQ® in the Chinese Language, currently in use at Sun Yat-sen University Cancer Center. MOSAIQ is Elekta's dedicated electronic oncology information system.
• Installation of China's first Leksell Gamma Knife® Perfexion™ radiosurgery systems at Zheijiang University School of Medicine and Beijing Tiantan Hospital. Shanghai Gamma Knife Hospital also plans to install a Perfexion system later this year.
• First order for Elekta Axesse™, an advanced 4D stereotactic treatment system designed to facilitate highly targeted stereotactic body radiation therapy (SBRT) and radiosurgery anywhere in the body recently was placed. 

Elekta also has enabled users of Precise Treatment System™ in China to increase treatment delivery speed with the release of VMAT (Volumetric Modulated Arc Therapy). VMAT is an advanced radiation therapy technique that delivers treatment in one or more continuous high-speed arcs around the patient, enabling the radiation dose to precisely conform to a tumor by modulating the radiation beam's intensity.

Precise Treatment System is a versatile therapy platform offering treatments with photons or electrons, traditional static delivery, IGRT or VMAT.

"During 2010-2011, Elekta solutions accounted for nearly half of new orders in the Chinese market, making Elekta the number one provider in the country," says Gilbert Wai, Executive Vice President, Asia Pacific. "Our ongoing mission is to help meet China's demand for comprehensive cancer management solutions as this nation's healthcare providers strive to offer the best services for its citizens."

Elekta's comprehensive radiation therapy solutions also will be on display (booth #H1-E36) at the Spring 2012 China International Medical Equipment Fair (CMEF), April 17-20 at the Shenzhen Convention and Exhibition Centre in Shenzhen.

For more information on Elekta China, visit www.elekta.cn. 

For further information, please contact:
Stina Thorman, Vice President Corporate Communications, Elekta AB 
Tel: +46 8 587 254 37, email: [email protected]
Time zone: CET: Central European Time

Michelle Lee Joiner, Director, Global Public Relations and Brand Management, Elekta 
Tel: +1 770-670-2447, email: [email protected] 
Time zone: ET: Eastern Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives. 

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

SOURCE Elekta